EPENDYMOMA
Clinical trials for EPENDYMOMA explained in plain language.
Never miss a new study
Get alerted when new EPENDYMOMA trials appear
Sign up with your email to follow new studies for EPENDYMOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Glowing dye could help surgeons spot hidden brain cancer
Disease control Not yet recruitingThis phase 2 trial tests a single dose of FG001, a fluorescent dye, in 76 adults with newly diagnosed high-grade glioma. The dye is given before surgery and glows under a special light, helping surgeons tell tumor from healthy tissue during removal. The study checks how well the …
Matched conditions: EPENDYMOMA
Phase: PHASE2 • Sponsor: FluoGuide A/S • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New proton therapy spares spine growth in kids with brain cancer
Disease control Not yet recruitingThis study looks at a new way to give radiation to children with brain tumors that need whole-brain and whole-spine treatment. The technique, called vertebral body-sparing proton therapy, aims to protect the front of the spine bones to preserve bone marrow and growth. Researchers…
Matched conditions: EPENDYMOMA
Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
Immune cells engineered to fight brain cancer in kids
Disease control Not yet recruitingThis early-phase study tests the safety of a new cell therapy called B7-H3 CAR T cells for children and young adults whose brain tumors have come back or are growing despite standard treatment. The therapy uses the patient's own immune cells, modified to target a protein (B7-H3) …
Matched conditions: EPENDYMOMA
Phase: PHASE1 • Sponsor: Robbie Majzner • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Personalized drug test aims to outsmart refractory brain tumors
Knowledge-focused Not yet recruitingThis study tests a lab technique called pharmacoscopy that analyzes a patient's tumor tissue to find which drugs might work best for them. It includes 40 adults with various aggressive or rare brain tumors that have not responded to standard treatments. The main goal is to see if…
Matched conditions: EPENDYMOMA
Phase: PHASE2 • Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC